Prognostic value of LncRNA PSMA3-AS1 in prostate cancer and its potential regulatory mechanism
Abstract Objective Prostate adenocarcinoma (PRAD) is asymptomatic in the early stages and most patients are diagnosed at an advanced stage, which leads to a poor prognosis. Therefore, an effective prognostic marker is required to improve PRAD prognosis. Methods A total of 128 patients with PRAD were...
Saved in:
| Main Authors: | Muyang Cao, Jin Li, Jianbin Zhang, Wenlong Lu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Hereditas |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s41065-025-00485-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Which PSMA PET/CT interpretation criteria most effectively diagnose prostate cancer? a retrospective cohort study
by: Le Ma, et al.
Published: (2025-01-01) -
LncRNA LINC01128 promotes prostate cancer cell proliferation, metastasis, and epithelial-mesenchymal transition by modulating miR-27b-3p
by: Yuhui Zhao, et al.
Published: (2025-03-01) -
The Expression and Regulatory Role of lncRNA CRNDE in Ischemic Stroke
by: Yuan Cheng, et al.
Published: (2025-04-01) -
Port site metastasis after robotic assisted laparoscopic radical prostatectomy: Diagnosis via prostate-specific membrane antigen (PSMA)-targeted 18F-DCFPyL PET/CT
by: Joon Yau Leong, et al.
Published: (2025-07-01) -
PSMA PET/CT scan reveals incidental meningioma in a prostate cancer patient
by: Venetia A. Florou, et al.
Published: (2025-05-01)